Redwood Investment Management LLC Purchases 84,303 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Redwood Investment Management LLC boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 67.0% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 210,179 shares of the pharmacy operator’s stock after purchasing an additional 84,303 shares during the quarter. Redwood Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $1,903,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Iron Horse Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 1,300 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 1,081 shares during the last quarter. Continuum Advisory LLC lifted its position in shares of Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares during the last quarter. Strategic Investment Solutions Inc. IL bought a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $34,000. Finally, First Personal Financial Services increased its stake in shares of Walgreens Boots Alliance by 83.3% during the second quarter. First Personal Financial Services now owns 3,300 shares of the pharmacy operator’s stock worth $40,000 after purchasing an additional 1,500 shares during the period. Institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on WBA shares. Barclays raised their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Bank of America reduced their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. Royal Bank of Canada reduced their target price on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. reduced their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a report on Friday, August 30th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $12.58.

Walgreens Boots Alliance Trading Down 3.1 %

NASDAQ WBA opened at $8.47 on Friday. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $27.05. The company has a market cap of $7.32 billion, a price-to-earnings ratio of -0.85, a price-to-earnings-growth ratio of 1.17 and a beta of 0.66. The business’s fifty day moving average is $9.17 and its 200 day moving average is $11.03.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the business posted $0.67 EPS. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 11.81%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s payout ratio is presently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.